Megamox-CV Duo Dry Syrup is a broad-spectrum antibiotic formulation combining Amoxycillin (400mg/5ml) and Clavulanic Acid (57mg/5ml) designed to treat a variety of bacterial infections. Amoxycillin, a semi-synthetic penicillin derivative, exhibits bactericidal activity by inhibiting bacterial cell wall synthesis. Clavulanic Acid acts as a beta-lactamase inhibitor, protecting Amoxycillin from enzymatic degradation by beta-lactamase-producing organisms, thereby extending its antimicrobial spectrum. This combination is effective against infections caused by susceptible strains of Gram-positive and Gram-negative bacteria, including respiratory tract infections, otitis media, sinusitis, urinary tract infections, skin and soft tissue infections, and dental infections. Megamox-CV Duo Dry Syrup is formulated as a dry powder for reconstitution, ensuring stability and ease of administration in pediatric and adult patients who have difficulty swallowing tablets. Dosage and duration of therapy should be guided by the severity of infection, patient age, weight, and renal function. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and vomiting. Hypersensitivity reactions, although rare, require immediate discontinuation. This product should be used under medical supervision to ensure appropriate indication and to minimize the risk of antibiotic resistance.